Berkman N - Search Results

1

The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma.

Bousquet J, Cabrera P, Berkman N, Buhl R, Holgate S, Wenzel S, Fox H, Hedgecock S, Blogg M, Cioppa GD. Bousquet J, et al. Among authors: berkman n. Allergy. 2005 Mar;60(3):302-8. doi: 10.1111/j.1398-9995.2004.00770.x. Allergy. 2005. PMID: 15679714

2

CD48 on blood leukocytes and in serum of asthma patients varies with severity.

Gangwar RS, Minai-Fleminger Y, Seaf M, Gutgold A, Shikotra A, Barber C, Chauhan A, Holgate S, Bradding P, Howarth P, Eliashar R, Berkman N, Levi-Schaffer F. Gangwar RS, et al. Among authors: berkman n. Allergy. 2017 Jun;72(6):888-895. doi: 10.1111/all.13082. Epub 2016 Dec 1. Allergy. 2017. PMID: 27859399

3

The effect of omalizumab treatment on the low affinity immunoglobulin E receptor (CD23/fc epsilon RII) in patients with severe allergic asthma.

Assayag M, Moshel S, Kohan M, Berkman N. Assayag M, et al. Among authors: berkman n. Allergy Asthma Proc. 2018 Jan 1;39(1):36-42. doi: 10.2500/aap.2018.39.4106. Allergy Asthma Proc. 2018. PMID: 29279058

4

The beneficial effects of Xolair (omalizumab) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available treatment (GINA 2002 step IV)--the Israeli arm of the INNOVATE study.

Sthoeger ZM, Eliraz A, Asher I, Berkman N, Elbirt D. Sthoeger ZM, et al. Among authors: berkman n. Isr Med Assoc J. 2007 Jun;9(6):472-5. Isr Med Assoc J. 2007. PMID: 17642399 Clinical Trial.

5

Modulation of allergic responses by mitochondrial STAT3 inhibitors.

Erlich TH, Sharkia I, Landolina N, Assayag M, Goldberger O, Berkman N, Levi-Schaffer F, Razin E. Erlich TH, et al. Among authors: berkman n. Allergy. 2018 Nov;73(11):2160-2171. doi: 10.1111/all.13467. Epub 2018 Oct 30. Allergy. 2018. PMID: 29683527

6

Osteopontin is expressed and functional in human eosinophils.

Puxeddu I, Berkman N, Ribatti D, Bader R, Haitchi HM, Davies DE, Howarth PH, Levi-Schaffer F. Puxeddu I, et al. Among authors: berkman n. Allergy. 2010 Feb;65(2):168-74. doi: 10.1111/j.1398-9995.2009.02148.x. Epub 2009 Oct 5. Allergy. 2010. PMID: 19804447

7

Dexamethasone and salbutamol stimulate human lung fibroblast proliferation.

Pickholtz E, Admon D, Izhar U, Berkman N, Levi-Schaffer F. Pickholtz E, et al. Among authors: berkman n. World Allergy Organ J. 2011 Dec;4(12):249-56. doi: 10.1097/WOX.0b013e31821d1186.. Epub 2011 Dec 14. World Allergy Organ J. 2011. PMID: 23268452 Free PMC article.

8

The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts.

Puxeddu I, Bader R, Piliponsky AM, Reich R, Levi-Schaffer F, Berkman N. Puxeddu I, et al. Among authors: berkman n. J Allergy Clin Immunol. 2006 Jan;117(1):103-10. doi: 10.1016/j.jaci.2005.08.057. Epub 2005 Dec 2. J Allergy Clin Immunol. 2006. PMID: 16387592

9

The role of eosinophil major basic protein in angiogenesis.

Puxeddu I, Berkman N, Nissim Ben Efraim AH, Davies DE, Ribatti D, Gleich GJ, Levi-Schaffer F. Puxeddu I, et al. Among authors: berkman n. Allergy. 2009 Mar;64(3):368-74. doi: 10.1111/j.1398-9995.2008.01822.x. Epub 2008 Dec 17. Allergy. 2009. PMID: 19120069

10

Airway eosinophil accumulation and eotaxin-2/CCL24 expression following allergen challenge in BALB/c mice.

Ben-Yehuda C, Bader R, Puxeddu I, Levi-Schaffer F, Breuer R, Berkman N. Ben-Yehuda C, et al. Among authors: berkman n. Exp Lung Res. 2008 Oct;34(8):467-79. doi: 10.1080/01902140802220625. Exp Lung Res. 2008. PMID: 18850374

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

246 results

Search Page